Flexibility of monochromator-based detection. Sensitivity of filter-based detection. Together in Synergy™ 4


BioTek's new patent pending Synergy 4 with Hybrid Technology (click to watch the video) combines two powerful fluorescence detection systems, monochromator-based and filter-based, in one compact unit. As a result, you can finally enjoy complete flexibility and instant control in assay choice for current as well as future demands. The result - the world's first true multi-mode system capable of performing an unlimited number of microplate-based assays.

• Certified by Cisbio for HTRF TR-FRET assays
  
• Certified by Promega for their luminescent Dual Luciferase Reporter (DLR) assay system
  
• Certified by Invitrogen for their fluorescent drug discovery assays:
  • LanthaScreen
    
  • Omnia
    
  • GeneBLAzer
    
  • Z'-LYTE
• AlphaScreen compatible
  
• Detection modes include:
  • UV-visible absorbance
    
  • Top/bottom fluorescence including FRET
    
  • Luminescence including BRET
    
  • Fluorescence polarization
    
  • Time-resolved fluorescence

The choice is yours.	Filter- based	Monochromator- based	Hybrid Technology
Spectral Scanning
Flexible wavelength selection
Convenience
High performance Fluorescence Polarization
High performance TRF / TR-FRET
High performance across spectrum
Ratiometric ion channel assays
Filtered luminescence (e.g. BRET)
AlphaScreen®

HTRF® and the HTRF logo are registered trademarks of Cisbio.
Dual-Luciferase is a trademark of Promega Corporation and is registered with the U.S. Patent and Trademark office.
AlphaScreen® is a registered trademark of Perkin Elmer.
Transcreener™ is a trademark of BellBrook Labs.
The LanthaScreen™ and GeneBLAzer® technologies from Invitrogen have been validated on BioTek instruments.